You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. FDA approves darolutamide for metastatic castration-sensitive prostate cancer
- 2. ESPN's Jay Harris Diagnosed With Prostate Cancer
- 3. It's my goal to live to 100 – and it's not just diet and exercise that will help me achieve it
- 4. Food-derived compounds targeting ferroptosis for cancer therapy: from effects to mechanisms
- 5. Why is there such a generational divide in views on sex and gender in Britain? | Susanna Rustin
- 6. Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection
- 7. Efficacy and safety of Eribulin-based chemotherapy in HER2 negative advanced breast cancer patients: a real-world study
- 8. Prediction of metastatic risk of renal clear cell carcinoma based on CT radiomics analysis
- 9. Case Report: Liver and bladder metastasis in a patient with HR-positive, HER2-low breast cancer
- 10. Avenzo begins Phase I/II trial of CDK4 selective inhibitor for breast cancer
Last updated at 20:05 GMT
Hot News Makers
Health/Pharma Companies
-
57016.43
-
45230.02
-
18369.19
-
8292.46
-
7066.87
-
5661.31
-
5630.20
-
5509.12
-
4512.14
-
4159.20
Drugs, Treatments, Trials
-
22987.58
-
9049.14
-
7530.39
-
7184.95
-
6268.32
-
5037.68
-
3390.08
-
2901.62
-
2777.39
-
2204.10
Last updated at 19:10 GMT
